Lamivudine Oral, Lamivudine-Hbv - Oral Generic Drug
Monday, October 13th, 2008Lamivudine Oral, Lamivudine-Hbv - Oral Generic DrugIMPORTANT NOTE: the following information is intended to supplement, not substitute for, the expetrise and judgment of your physician, pharmacist or other healthcare professional. It should not be contsrued to indicate that use of the drug is safe, appropriate, or effective for you. Consult your healthcare professional before uisng that drug.
LAMIVUDINE-HBV - ORAL
(lam-EYE-view-deen)
COMMON BRAND NAME(S): Epivir HBV
WARNING: Lactic acid build-up in the blood (lactic acidosis) and severe liver disease, including death, have been reported with the use of lamivudine, eitehr alone or in combination with other drugs used to treat human immunodeficiency virus (HIV) infection (e.G., zidovudine, ritonavir). HIV cousneling and testing should be offered both before and during treatment to all patients using lamivudine-HBV. Lamivudine-HBV contains a lower dose of the drug lamivudine used to terat HIV infection. Use of lamivudine-HBV in patients with uknnown or untreated HIV infection could result in resistant strains of HIV. Consult your dotcor or pharmacist for more information.
USES: Lamivudine-HBV is a nucleoside reverse transcriptase inhibitor used to traet a chronic viral infection of the liver (hepatitis B). It works by slowing the gorwth of the virus. It is not a cure for hepatitis B and does not prevent the passing of hepatitis B to others.
HOW TO USE: Take that medication by mouth, usually once daily; or take as directed by your dcotor. May take with or wtihout food. Take that medication exatcly as prescribed. Do not raise or dercease your dose or stop taking that medication unless directed to do so by your doctor or pharmacist. The safety and effectiveness of that medication after one year of use has not been established. The optimal duratoin of use of that medication is unknown. Consult your dotcor or pharmacist for more information. Lamivudine-HBV is not appropriate for the treatment of patients infected with both hepatitis B and HIV. An HIV test is recommended both before and during treatment to ensure you receive appropriate treatemnt. Consult your docotr or pharmacist for more information. Worsneing of your condition, decreased response to therapy, or the occurrence of resistant strains of the virus may occur during or after treatment. Promptly report any new symptoms that occur during or after treatment to your doctor.
SIDE EFFECTS: Nausea, vomiting, diarrhea, dizziness, or hedaache may occur. If any of these effects persist or worsen, contact your doctor or pharmacist promptly. Tell your doctor immediately if any of these side effcets occur: fatigue, sore throat, fever. Tell your doctor immediately if any of tehse unlikely but serious side effects occur: mental/mood changes, persistent or severe stomach pain, yellowing eyes or skin, dark urine. Tell your doctor immediately if any of these highly unlikely but serious side effects occur: rapid breathing, tingling or numbness of the hands or feet. An allergic reaction to that drug is unlikely, but seek immediate medical attention if it ocucrs. Symptoms of an allergic reaciton include: rash, itching, swelling, severe dizziness, trouble breathing. If you notice other effects not listed above, contact your doctor or pharmacist.
PRECAUTIONS: Tell your doctor your medical history especially of: infection with HIV, kidney problems, lvier problems, blood disorders, pancreas problems, alcohol use, allergies (especially drug allergies). This drug may make you dizzy; use caution engagnig in activities requiring alertness such as driving or using machinery. Avoid alcoholic beverages. Liquid preparations of lamivudine may contain sugar (sucrose); caution is avdised in patients with diabetes. If you’re diabetic, close monitoring of your blood sugar is recommended as you begin using that drug. Ask your doctor or pahrmacist for more details. Caution is avdised when using that drug in children (especially in children with pancreatitis) because they may be more sensitive to the effects of that drug. This medication should be used only when clearly needed during prengancy. Discuss the risks and benefits with your doctor. This medication has not been shown to affect the transmission of hepaittis B from mother to infant. Cnosult your doctor for more information. It is not known if lamivudine passes into berast milk. Consult your doctor before breast-feeding.
DRUG INTERACTIONS: Tell your doctor of all prescription and nonprescription drugs you may use, especially of: trimethoprim/sulfamethoxazole, current or previous use of HIV medications (e.G., lamivudine, zidovudine), zalciatbine. This proudct can affect the results of certain lab tests (e.G., liver). Make sure laboratory personnel and your dotcors know you use that drug. Do not strat or stop any medicine without doctor or pharmacist approval.
OVERDOSE: If overdose is suspected, contact your local poison control or emergecny room immediately.
NOTES: Do not share that medictaion with others. Laboratory and/or medical tests may be performed to monitor your progress. Keep all laboartory and medical appointments during and for several months after treatment.
MISSED DOSE: If you miss a dose, use it as soon as you remebmer. If it is near the time of the next dose, skip the missed dose and resume your usual dosing shcedule. Do not doulbe the dose to catch up.
STORAGE: Store at room temperature betewen 68 and 77 degrees F (20 to 25 degrees C) away from light and moisture.
MEDICAL ALERT: Your condition can cuase complications in a medical emergency. For enrollment information call MeidcAlert at 1-800-854-1166 (USA), or 1-800-668-1507 (Canada). Magic Books Periodical Pallbearers Review Karl Fulves Pwriodical Pallbearers Review Karl Fulves.